CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Purdue Pharma L.P. v. Amneal Pharmaceuticals, LLC

1:13-cv-03372

Overview

Case Number 1:13-cv-03372
Filing Date 2013-05-17
Status Terminated
Termination Date 2015-04-09
Court District Court, S.D. New York (nysd)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Amneal Pharmaceuticals, LLC Operating Company

Represented By

1 Attorneys Listed

Plaintiff

Purdue Pharmaceuticals, LLC NPE (University / Research)

Represented By

3 Attorneys Listed

Pablo Daniel Hendler

Ropes & Gray, LLP (NYC)

Tel: +1 (212) 596-9000
Fax: +1 (212) 596-9090

1211 Avenue of the Americas, New York, NY 10036

Sona De

Ropes & Gray, LLP

Tel: +1 (212) 596-9000
Fax: +1 (646) 728-2650

1211 Avenue of the Americas, New York, NY 10036

Robert J. Goldman

Ropes & Gray, LLP (CA)

Tel: +1 (650) 617-4035
Fax: +1 (650) 617-4090

1900 University Avenue, 6th Floor

Counter Defendant

The P.F. Laboratories, Inc. Operating Company

Represented By

3 Attorneys Listed

Pablo Daniel Hendler

Ropes & Gray, LLP (NYC)

Tel: +1 (212) 596-9000
Fax: +1 (212) 596-9090

1211 Avenue of the Americas, New York, NY 10036

Sona De

Ropes & Gray, LLP

Tel: +1 (212) 596-9000
Fax: +1 (646) 728-2650

1211 Avenue of the Americas, New York, NY 10036

Robert J. Goldman

Ropes & Gray, LLP (CA)

Tel: +1 (650) 617-4035
Fax: +1 (650) 617-4090

1900 University Avenue, 6th Floor

Purdue Pharma L.P. NPE (University / Research)

Represented By

3 Attorneys Listed

Pablo Daniel Hendler

Ropes & Gray, LLP (NYC)

Tel: +1 (212) 596-9000
Fax: +1 (212) 596-9090

1211 Avenue of the Americas, New York, NY 10036

Sona De

Ropes & Gray, LLP

Tel: +1 (212) 596-9000
Fax: +1 (646) 728-2650

1211 Avenue of the Americas, New York, NY 10036

Robert J. Goldman

Ropes & Gray, LLP (CA)

Tel: +1 (650) 617-4035
Fax: +1 (650) 617-4090

1900 University Avenue, 6th Floor

Court & Judges

Court

District Court, S.D. New York (nysd)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 22 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (22): πŸ‡©πŸ‡ͺ Germany πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US8114383
Abuse-proofed dosage form
Filed: 2003-11-20
Issued: 2012-02-14
Expired (Term Ended) +325d PTA
Expires: 2024-10-10
US8337888
Pharmaceutical formulation containing gelling agent
Filed: 2012-01-12
Issued: 2012-12-25
Active (5.1 yrs remaining)
Expires: 2032-01-12

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+325 days) / In re Cellect scrutiny applies.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

10

Dispositive

0

Granted

0

Denied

1

Pending / Review

9

Motions by Category

Claim Construction / Markman Filing 10

Key Dispositive Motions & Rulings

Claim Construction / Markman Filing Denied
ORDER: Plaintiffs have moved in limine to preclude defendant Teva from "supplementing its expert reports to offer any expert testimony regarding the validity of...
Entry #42 • 2014-07-11 Document →
Claim Construction / Markman Filing Pending / Under Review
OPINION & ORDER: The '888 and '060 patents will now proceed to trial. On the basis of the claim construction set forth herein, the Court will determine whether ...
Entry #26 • 2014-05-27 Document →
Claim Construction / Markman Filing Pending / Under Review
ENDORSED LETTER addressed to Judge Sidney H. Stein from Mark D. Schuman dated 3/4/2014 re: Counsel for Teva Pharmaceuticals USA, Inc., requests permission to be...
Entry #24 • 2014-03-04 Document →
Claim Construction / Markman Filing Pending / Under Review
DECLARATION of Martyn C. Davies, Ph.D. in Support of Plaintiffs' Responsive Claim Construction Brief. Document filed by Purdue Pharma L.P., Purdue Pharmaceutica...
Entry #21 • 2014-02-14 Document →
Claim Construction / Markman Filing Pending / Under Review
CLAIM CONSTRUCTION STATEMENT. Document filed by Purdue Pharma L.P., Purdue Pharmaceuticals, LLC, The P.F. Laboratories, Inc..(Goldman, Robert) (Entered: 01/15/2...
Entry #15 • 2014-01-15 Document →
Claim Construction / Markman Filing Pending / Under Review
DECLARATION of Rebecca R. Hermes re: 15 Claim Construction Statement. Document filed by Purdue Pharma L.P., Purdue Pharmaceuticals, LLC, The P.F. Laboratories, ...
Entry #16 • 2014-01-15 Document →

Docket Entries

(91 total)
Pleading / Complaint

COMPLAINT against Amneal Pharmaceuticals, LLC. (Filing Fee $ 350.00, Receipt Number 465401067862)Document filed by The P.F. Laboratories, Inc., Purdue Pharma L.P., Purdue Pharmaceuticals, LLC.(cde) (Entered: 05/22/2013)

Entry #1 • 2013-05-17
1
Court Order

STANDING ORDER IN RE PILOT PROJECT REGARDING CASE MANAGEMENT TECHNIQUES FOR COMPLEX CIVIL CASES IN THE SOUTHERN DISTRICT OF NEW YORK (See M-10-468 Order filed November 1, 2011). This case is hereby designated for inclusion in the Pilot Project Regarding Case Management Techniques for Complex Civil Cases in the Southern District of New York (the Pilot Project), unless the judge to whom this case is assigned determines otherwise. This case is designated for inclusion in the Pilot Project because it is a class action, an MDL action, or is in one of the following Nature of Suit categories: 160, 245, 315, 355, 365, 385, 410, 830, 840, 850, 893, or 950. The presiding judge in a case that does not otherwise qualify for inclusion in the Pilot Project may nevertheless designate the case for inclusion in the Pilot Project by issuing an order directing that the case be included in the Pilot Project. The description of the Pilot Project, including procedures to be followed, is attached to this Order. (Signed by Judge Loretta A. Preska on 10/31/2011) (cde) (Entered: 05/22/2013)

Entry #2 • 2013-05-17
1

RULE 7.1 CORPORATE DISCLOSURE STATEMENT. Identifying Other Affiliate Purdue Holdings L.P. for Purdue Pharma L.P.; Other Affiliate Purdue Pharma L.P. for Purdue Pharmaceuticals, LLC; Corporate Parent Pharmaceutical Research Associates, Inc. for The P.F. Laboratories, Inc.. Document filed by Purdue Pharma L.P., Purdue Pharmaceuticals, LLC, The P.F. Laboratories, Inc..(Hendler, Pablo) (Entered: 05/23/2013)

Entry #3 • 2013-05-23
1

NOTICE OF CASE ASSIGNMENT to Judge Sidney H. Stein. Judge Unassigned is no longer assigned to the case. (pgu) (Entered: 05/28/2013)

Entry #4 • 2013-05-28
1

RULE 7.1 CORPORATE DISCLOSURE STATEMENT. Identifying Corporate Parent Amneal Holdings, LLC, Corporate Parent Amneal Pharmaceutical Holdings Company LLC for Amneal Pharmaceuticals, LLC. Document filed by Amneal Pharmaceuticals, LLC.(Sender, Stuart) (Entered: 06/17/2013)

Entry #5 • 2013-06-17
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc